Neuland Labs launches dedicated peptide manufacturing module
The Indian contract developer and manufacturer adds capacity aimed at peptide active ingredients as demand for synthetic peptide APIs grows.
TR
By Tom Reyes · Markets Editor
Sep 16 23:34 ETSource: Contract Pharma
The wire
- 01Neuland Laboratories said it has launched a peptide manufacturing module, expanding its contract development and manufacturing footprint for peptide active pharmaceutical ingredients.
- 02Peptide API capacity is a bottleneck across the field, so added CDMO lines matter to sponsors and compounders sourcing GMP material.
- 03Details on scale, technology and customer commitments were not disclosed in the announcement.
From the source
Read at contractpharma.comNeuland Launches Peptide Manufacturing Module